首页> 外文期刊>Drugs of the Future >AMERICAN SOCIETY OF CLINICAL ONCOLOGY-51ST ANNUAL MEETING CHICAGO, ILLINOIS, USA - MAY 29-JUNE 2, 2015
【24h】

AMERICAN SOCIETY OF CLINICAL ONCOLOGY-51ST ANNUAL MEETING CHICAGO, ILLINOIS, USA - MAY 29-JUNE 2, 2015

机译:美国芝加哥临床肿瘤学会第51届年会,美国伊利诺伊州-2015年5月29日至6月2日

获取原文
获取原文并翻译 | 示例
       

摘要

The 51st annual meeting of the American Society of Clinical Oncology (ASCO) took place from May 29 to June 2, 2015. The conference was attended by a global contingent of more than 30,000 oncology professionals. Some of the research topics discussed were immunotherapy, combination therapies, genetically targeted treatments, radiation and technologies to improve patients' quality of life. The overall theme for the conference concerned the integration of scientific innovations in oncology with health information technology to provide enhanced patient care. In that regard, in addition to current research, health information technology innovations were also discussed (e.g., CancerLinQ). This report covers a few of those important discussions.
机译:2015年5月29日至6月2日,举行了第51届美国临床肿瘤学会(ASCO)年度会议。全球30,000多名肿瘤学专业人士参加了该会议。讨论的一些研究主题是免疫疗法,联合疗法,基因靶向治疗,放射治疗和改善患者生活质量的技术。会议的总体主题涉及将肿瘤学领域的科学创新与健康信息技术相结合,以提供更好的患者护理。在这方面,除了当前的研究之外,还讨论了健康信息技术的创新(例如,CancerLinQ)。本报告涵盖了其中一些重要的讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号